Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer
Clinical trial NCT00635726 · TERMINATED
Trial details
- NCT number
- NCT00635726
- Sponsor
- Hellenic Oncology Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2013-02-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.